Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 2025 in its research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results